Efficacy of Automated Distal Vascular Anastomosis in Coronary Surgery: Phase II
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Leipzig, Germany, D-04289
- Klinik für Herzchirurgie
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Age between 50 and 85 years (inclusive)
- Diagnostically confirmed coronary disease
- Ejection fraction > 30%
- Tolerate contrast media
- Acceptable LIMA (conduit) and LAD (target)for grafting
- Life expectancy > 1 year
Exclusion Criteria:
- Refusal to give informed consent
- Unable to meet study travel and general health requirements
- Pregnancy
- Previous cardiac surgery
- NYHA Class IV
- Preoperative need for IABP
- Acute or chronic dialysis (creatinine > 200mmolor 2.3 mg/dL) within 30 days of surgery
- Acute or suspected systemic infection
- Need for ongoing immunosuppressive therapy
- Recent history (<2 weeks) of CVA
- Aspirin allergy
Study Plan
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: NON_RANDOMIZED
- Interventional Model: SINGLE_GROUP
- Masking: NONE
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
NO_INTERVENTION: C-Port
Automated distal anastomotic device
|
CABG
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Coronary patency of index graft at the sixth post-operative month
Time Frame: 6 months post-op
|
6 months post-op
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Establish preliminary safety profile
Time Frame: 6 months post-op
|
6 months post-op
|
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Principal Investigator: Jan Gummert, MD, Herzzentrum Leipzig GmbH
Study record dates
Study Major Dates
Study Start
Study Start
Primary Completion (ACTUAL)
Primary Completion
Study Completion (ACTUAL)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (ESTIMATE)
First Posted
Study Record Updates
Last Update Posted (ESTIMATE)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- IP2004-06
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.